Search clinical trials for: ESL - Open-label Extension (Part II)
Total 34 results
-
ES Therapeutics Australia Pty LtdRecruitingDrug Resistant EpilepsyAustralia
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Bial - Portela C S.A.CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyPartial EpilepsyPortugal
-
Scion NeuroStimEnrolling by invitationParkinson Disease | Parkinson's Disease and ParkinsonismUnited States
-
Aldeyra Therapeutics, Inc.Recruiting
-
Opsidio, LLCInnovaderm Research Inc.Active, not recruitingAtopic DermatitisCanada, United States
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
Mineralys Therapeutics Inc.Recruiting
-
Bellerophon Pulse TechnologiesTerminatedPulmonary Fibrosis | Pulmonary HypertensionUnited States, Canada
-
Kezar Life Sciences, Inc.RecruitingAutoimmune HepatitisUnited States
-
Bial - Portela C S.A.Completed
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis Complex-associated Refractory SeizuresUnited States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
-
Boehringer IngelheimCompleted
-
Trevena Inc.Completed
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Boehringer IngelheimCompleted
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
Furiex Pharmaceuticals, IncTerminatedCommunity-Acquired Bacterial Pneumonia (CABP)United States, Canada, Colombia, Germany, Hungary, Poland
-
Bezmialem Vakif UniversityCompletedLower Abdominal SurgeryTurkey
-
Oregon Health and Science UniversityPfizerCompletedSarcoidosis | Sarcoidosis, Pulmonary | Sarcoidosis LungUnited States
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingClassical Hodgkin LymphomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedPeripheral T Cell Lymphoma | Treatment-naïveChina
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Jilin UniversityUnknownAntineoplastic Combined Chemotherapy ProtocolsChina
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
Korea UniversityCompletedPrimary Spontaneous PneumothoraxKorea, Republic of
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States